StonvexLoading…
StonvexStonvexStonvexCore line items from THC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $21.31B | $20.68B | $20.56B | $19.17B |
Operating Income | $3.51B | $5.96B | $2.51B | $2.33B |
Net Income | $2.37B | $4.06B | $1.31B | $1.00B |
EPS (Diluted) | $15.49 | $32.70 | $5.71 | $3.79 |
Total Assets | $29.68B | $28.94B | $28.31B | $27.16B |
Total Liabilities | $20.70B | $20.39B | $22.80B | $22.55B |
Cash & Equivalents | $2.88B | $3.02B | $1.23B | $858.00M |
Free Cash Flow OCF − CapEx | $2.53B | $1.12B | $1.62B | $321.00M |
Shares Outstanding | 90.83M | 97.88M | 104.80M | 110.52M |